Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Clinical trial NCT00243867 · COMPLETED

Trial details

NCT number: NCT00243867
Sponsor: American Regent, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2005-11-01
Primary completion: 2008-08-01
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.